Inpharma Weekly

, Volume 1347, Issue 1, pp 8–8 | Cite as

CD4+ cell count dominant prognostic factor in patients starting HAART

Clinical study
  • 3 Downloads

Keywords

Adjusted Hazard Ratio Multinational Group Poor Disease Collaboration Study Collaborative Analysis 

Copyright information

© Adis International Ltd 2002

Personalised recommendations